Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Innere Medizin (Heidelberg, Germany)|June 20, 2024
[Thyroid carcinomas: the role of systemic therapies in internal medicine]Tim Brandenburg, Matthias Kroiß
Innere Medizin (Heidelberg, Germany)|January 17, 2024
[Precision medicine in endocrinology exemplified by medullary thyroid cancer]Tim Brandenburg, Yara Maria Machlah, Dagmar Führer
Laryngo- Rhino- Otologie|February 12, 2024
[Systemic therapies for advanced thyroid cancer - an update]Tim Brandenburg, Yara Maria Machlah, Dagmar Führer-Sakel
Deutsche Medizinische Wochenschrift (1946)|November 2, 2023
[Systemic therapies for advanced thyroid cancer - an update]Tim Brandenburg, Yara Maria Machlah, Dagmar Führer-Sakel
European Thyroid Journal|December 27, 2021
Therapeutic Effect of Combined Dabrafenib and Trametinib Treatment of BRAF V600E-Mutated Primary Squamous Cell Carcinoma of the Thyroid: A Case ReportTim Brandenburg, Philipp Muchalla, Sarah Theurer, et al.
Cancers|March 13, 2024
Latest Progress in Risk-Adapted Surgery for Medullary Thyroid CancerAndreas Machens, Kerstin Lorenz, Tim Brandenburg, et al.
The Journal of Clinical Endocrinology and Metabolism|March 17, 2023
The Changing Face of Multiple Endocrine Neoplasia 2A: From Symptom-Based to Preventative MedicineAndreas Machens, Kerstin Lorenz, Tim Brandenburg, et al.
Endocrine-Related Cancer|May 16, 2024
Genotype-specific development of MEN 2 constituent components in 683 RET carriersAndreas Machens, Kerstin Lorenz, Frank Weber, et al.
Endocrine|July 21, 2023
Clinical presentation of MEN 2A in index vs. non-index patientsAndreas Machens, Kerstin Lorenz, Frank Weber, et al.
The Journal of Clinical Endocrinology and Metabolism|November 15, 2023
Risk and Incidence of Endocrine Immune-Related Adverse Effects Under Checkpoint Inhibitor Mono- or Combination Therapy in Solid Tumors: A Meta-Analysis of Randomized Controlled TrialsIrfan Vardarli, Susanne Tan, Tim Brandenburg, et al.
Pageof 4